2-[[2-[[1-[3-[5-[[(3R,4R,5R)-5-(aminomethyl)-4-hydroxy-3-methoxyoxolan-2-yl]oxy-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-dodecyl-2,4-dioxoimidazolidin-1-yl]propylamino]-3-hydroxy-4-methyl-1-oxopentan-2-yl]amino]-1-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-oxoethyl]carbamoylamino]-3-methylbutanoic acid

C51H86N12O17 — CID 10486413

IUPAC2-[[2-[[1-[3-[5-[[(3R,4R,5R)-5-(aminomethyl)-4-hydroxy-3-methoxyoxolan-2-yl]oxy-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-dodecyl-2,4-dioxoimidazolidin-1-yl]propylamino]-3-hydroxy-4-methyl-1-oxopentan-2-yl]amino]-1-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-oxoethyl]carbamoylamino]-3-methylbutanoic acid
SMILESCCCCCCCCCCCCN1C(=O)C(C(OC2O[C@H](CN)[C@@H](O)[C@H]2OC)[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2O)N(CCCNC(=O)C(NC(=O)C(NC(=O)NC(C(=O)O)C(C)C)C2CCN=C(N)N2)C(O)C(C)C)C1=O
InChIInChI=1S/C51H86N12O17/c1-7-8-9-10-11-12-13-14-15-16-22-62-44(71)34(39(80-47-41(77-6)36(66)29(25-52)78-47)40-37(67)38(68)45(79-40)63-24-19-30(64)57-50(63)75)61(51(62)76)23-17-20-54-42(69)33(35(65)27(4)5)58-43(70)32(28-18-21-55-48(53)56-28)60-49(74)59-31(26(2)3)46(72)73/h19,24,26-29,31-41,45,47,65-68H,7-18,20-23,25,52H2,1-6H3,(H,54,69)(H,58,70)(H,72,73)(H3,53,55,56)(H,57,64,75)(H2,59,60,74)/t28?,29-,31?,32?,33?,34?,35?,36-,37+,38-,39?,40+,41-,45-,47?/m1/s1
InChIKeyKXWDLKTXRHXRRL-KZYWNPAMSA-N
MW1139.32 g/mol
LogP-2.38
Rot. Bonds32

About 2-[[2-[[1-[3-[5-[[(3R,4R,5R)-5-(aminomethyl)-4-hydroxy-3-methoxyoxolan-2-yl]oxy-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-dodecyl-2,4-dioxoimidazolidin-1-yl]propylamino]-3-hydroxy-4-methyl-1-oxopentan-2-yl]amino]-1-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-oxoethyl]carbamoylamino]-3-methylbutanoic acid

2-[[2-[[1-[3-[5-[[(3R,4R,5R)-5-(aminomethyl)-4-hydroxy-3-methoxyoxolan-2-yl]oxy-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-dodecyl-2,4-dioxoimidazolidin-1-yl]propylamino]-3-hydroxy-4-methyl-1-oxopentan-2-yl]amino]-1-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-oxoethyl]carbamoylamino]-3-methylbutanoic acid (PubChem CID 10486413) has the molecular formula C51H86N12O17 and a molecular weight of 1139.32 g/mol. Its IUPAC name is 2-[[2-[[1-[3-[5-[[(3R,4R,5R)-5-(aminomethyl)-4-hydroxy-3-methoxyoxolan-2-yl]oxy-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-dodecyl-2,4-dioxoimidazolidin-1-yl]propylamino]-3-hydroxy-4-methyl-1-oxopentan-2-yl]amino]-1-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-oxoethyl]carbamoylamino]-3-methylbutanoic acid.

Molecular Properties

Compound Name2-[[2-[[1-[3-[5-[[(3R,4R,5R)-5-(aminomethyl)-4-hydroxy-3-methoxyoxolan-2-yl]oxy-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-dodecyl-2,4-dioxoimidazolidin-1-yl]propylamino]-3-hydroxy-4-methyl-1-oxopentan-2-yl]amino]-1-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-oxoethyl]carbamoylamino]-3-methylbutanoic acid
PubChem CID10486413
Molecular FormulaC51H86N12O17
Molecular Weight1139.32 g/mol
Exact Mass1138.62
IUPAC Name2-[[2-[[1-[3-[5-[[(3R,4R,5R)-5-(aminomethyl)-4-hydroxy-3-methoxyoxolan-2-yl]oxy-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-dodecyl-2,4-dioxoimidazolidin-1-yl]propylamino]-3-hydroxy-4-methyl-1-oxopentan-2-yl]amino]-1-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-oxoethyl]carbamoylamino]-3-methylbutanoic acid
SMILESCCCCCCCCCCCCN1C(=O)C(C(OC2O[C@H](CN)[C@@H](O)[C@H]2OC)[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2O)N(CCCNC(=O)C(NC(=O)C(NC(=O)NC(C(=O)O)C(C)C)C2CCN=C(N)N2)C(O)C(C)C)C1=O
InChIInChI=1S/C51H86N12O17/c1-7-8-9-10-11-12-13-14-15-16-22-62-44(71)34(39(80-47-41(77-6)36(66)29(25-52)78-47)40-37(67)38(68)45(79-40)63-24-19-30(64)57-50(63)75)61(51(62)76)23-17-20-54-42(69)33(35(65)27(4)5)58-43(70)32(28-18-21-55-48(53)56-28)60-49(74)59-31(26(2)3)46(72)73/h19,24,26-29,31-41,45,47,65-68H,7-18,20-23,25,52H2,1-6H3,(H,54,69)(H,58,70)(H,72,73)(H3,53,55,56)(H,57,64,75)(H2,59,60,74)/t28?,29-,31?,32?,33?,34?,35?,36-,37+,38-,39?,40+,41-,45-,47?/m1/s1
InChIKeyKXWDLKTXRHXRRL-KZYWNPAMSA-N
XLogP-2.38
TPSA426.38 Ų
H-Bond Donors13
H-Bond Acceptors21
Rotatable Bonds32
Heavy Atoms80
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001139.32
LogP ≤ 5-2.38
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze 2-[[2-[[1-[3-[5-[[(3R,4R,5R)-5-(aminomethyl)-4-hydroxy-3-methoxyoxolan-2-yl]oxy-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-dodecyl-2,4-dioxoimidazolidin-1-yl]propylamino]-3-hydroxy-4-methyl-1-oxopentan-2-yl]amino]-1-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-oxoethyl]carbamoylamino]-3-methylbutanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[[2-[[1-[3-[5-[[(3R,4R,5R)-5-(aminomethyl)-4-hydroxy-3-methoxyoxolan-2-yl]oxy-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-dodecyl-2,4-dioxoimidazolidin-1-yl]propylamino]-3-hydroxy-4-methyl-1-oxopentan-2-yl]amino]-1-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-oxoethyl]carbamoylamino]-3-methylbutanoic acid?
The IUPAC name of 2-[[2-[[1-[3-[5-[[(3R,4R,5R)-5-(aminomethyl)-4-hydroxy-3-methoxyoxolan-2-yl]oxy-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-dodecyl-2,4-dioxoimidazolidin-1-yl]propylamino]-3-hydroxy-4-methyl-1-oxopentan-2-yl]amino]-1-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-oxoethyl]carbamoylamino]-3-methylbutanoic acid (CID 10486413) is 2-[[2-[[1-[3-[5-[[(3R,4R,5R)-5-(aminomethyl)-4-hydroxy-3-methoxyoxolan-2-yl]oxy-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-dodecyl-2,4-dioxoimidazolidin-1-yl]propylamino]-3-hydroxy-4-methyl-1-oxopentan-2-yl]amino]-1-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-oxoethyl]carbamoylamino]-3-methylbutanoic acid.
What is the SMILES notation for 2-[[2-[[1-[3-[5-[[(3R,4R,5R)-5-(aminomethyl)-4-hydroxy-3-methoxyoxolan-2-yl]oxy-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-dodecyl-2,4-dioxoimidazolidin-1-yl]propylamino]-3-hydroxy-4-methyl-1-oxopentan-2-yl]amino]-1-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-oxoethyl]carbamoylamino]-3-methylbutanoic acid?
The canonical SMILES for 2-[[2-[[1-[3-[5-[[(3R,4R,5R)-5-(aminomethyl)-4-hydroxy-3-methoxyoxolan-2-yl]oxy-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-dodecyl-2,4-dioxoimidazolidin-1-yl]propylamino]-3-hydroxy-4-methyl-1-oxopentan-2-yl]amino]-1-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-oxoethyl]carbamoylamino]-3-methylbutanoic acid is CCCCCCCCCCCCN1C(=O)C(C(OC2O[C@H](CN)[C@@H](O)[C@H]2OC)[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2O)N(CCCNC(=O)C(NC(=O)C(NC(=O)NC(C(=O)O)C(C)C)C2CCN=C(N)N2)C(O)C(C)C)C1=O.
What is the InChIKey of 2-[[2-[[1-[3-[5-[[(3R,4R,5R)-5-(aminomethyl)-4-hydroxy-3-methoxyoxolan-2-yl]oxy-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-dodecyl-2,4-dioxoimidazolidin-1-yl]propylamino]-3-hydroxy-4-methyl-1-oxopentan-2-yl]amino]-1-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-oxoethyl]carbamoylamino]-3-methylbutanoic acid?
The InChIKey is KXWDLKTXRHXRRL-KZYWNPAMSA-N. The full InChI is InChI=1S/C51H86N12O17/c1-7-8-9-10-11-12-13-14-15-16-22-62-44(71)34(39(80-47-41(77-6)36(66)29(25-52)78-47)40-37(67)38(68)45(79-40)63-24-19-30(64)57-50(63)75)61(51(62)76)23-17-20-54-42(69)33(35(65)27(4)5)58-43(70)32(28-18-21-55-48(53)56-28)60-49(74)59-31(26(2)3)46(72)73/h19,24,26-29,31-41,45,47,65-68H,7-18,20-23,25,52H2,1-6H3,(H,54,69)(H,58,70)(H,72,73)(H3,53,55,56)(H,57,64,75)(H2,59,60,74)/t28?,29-,31?,32?,33?,34?,35?,36-,37+,38-,39?,40+,41-,45-,47?/m1/s1.
What are the key properties of 2-[[2-[[1-[3-[5-[[(3R,4R,5R)-5-(aminomethyl)-4-hydroxy-3-methoxyoxolan-2-yl]oxy-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-dodecyl-2,4-dioxoimidazolidin-1-yl]propylamino]-3-hydroxy-4-methyl-1-oxopentan-2-yl]amino]-1-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-oxoethyl]carbamoylamino]-3-methylbutanoic acid?
2-[[2-[[1-[3-[5-[[(3R,4R,5R)-5-(aminomethyl)-4-hydroxy-3-methoxyoxolan-2-yl]oxy-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-dodecyl-2,4-dioxoimidazolidin-1-yl]propylamino]-3-hydroxy-4-methyl-1-oxopentan-2-yl]amino]-1-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-oxoethyl]carbamoylamino]-3-methylbutanoic acid has a molecular weight of 1139.32 g/mol, XLogP of -2.38, 32 rotatable bonds, 13 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[[2-[[1-[3-[5-[[(3R,4R,5R)-5-(aminomethyl)-4-hydroxy-3-methoxyoxolan-2-yl]oxy-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-dodecyl-2,4-dioxoimidazolidin-1-yl]propylamino]-3-hydroxy-4-methyl-1-oxopentan-2-yl]amino]-1-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-oxoethyl]carbamoylamino]-3-methylbutanoic acid is sourced from PubChem (CID 10486413), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).